NRx Pharmaceuticals Announces Enrollment of First Patient in Phase II Study of Bipolar Depression with Sub-Acute Suicidality

NRx Pharmaceuticals, Inc., enrolled its first patient in one of two psychiatry studies being initiated this year; this first trial is studying patients with...

Related Keywords

United States ,Daniele Troy ,Chaim Hurvitz ,Sherry Glied ,Tom Johnson ,Molly Cogan ,Robert Besthof ,Jonathan Javitt ,Global Communications ,Drug Administration ,Phd Us Army ,United States National Security Advisor ,Nrx Pharmaceuticals Inc ,Nrx Pharmaceuticals ,Nasdaq ,Source Nrx Pharmaceuticals Inc ,Nrxp Nrx Pharmaceuticals ,Pfizer ,Teva International Group ,Us National Institutes Of Health ,Fast Track ,Breakthrough Therapy ,Special Protocol Agreement ,Biomarker Letter ,Prof Jonathan Javitt ,Chief Counsel ,Securities Litigation Reform Act ,Nc ,